Motley Fool Wealth Management LLC Sells 74,388 Shares of Kenvue Inc. $KVUE

Motley Fool Wealth Management LLC trimmed its holdings in Kenvue Inc. (NYSE:KVUE) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 255,691 shares of the company’s stock after selling 74,388 shares during the quarter. Motley Fool Wealth Management LLC’s holdings in Kenvue were worth $4,411,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of KVUE. Norges Bank bought a new stake in Kenvue in the 4th quarter worth about $756,862,000. Van ECK Associates Corp increased its holdings in Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after buying an additional 9,240,434 shares in the last quarter. ING Groep NV increased its holdings in Kenvue by 1,311.9% in the 4th quarter. ING Groep NV now owns 9,856,090 shares of the company’s stock worth $170,018,000 after buying an additional 9,157,999 shares in the last quarter. American Century Companies Inc. increased its holdings in Kenvue by 22.4% in the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after buying an additional 6,781,640 shares in the last quarter. Finally, Bessemer Group Inc. increased its holdings in Kenvue by 156.2% in the 4th quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock worth $146,475,000 after buying an additional 5,177,404 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

KVUE has been the subject of several research analyst reports. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Weiss Ratings downgraded Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Canaccord Genuity Group lifted their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. UBS Group reduced their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Finally, Citigroup dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and an average target price of $19.33.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.59% of the company’s stock.

Kenvue Stock Up 2.0%

KVUE stock opened at $17.91 on Wednesday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The stock has a market cap of $34.38 billion, a P/E ratio of 21.06, a PEG ratio of 1.33 and a beta of 0.54. The business’s 50-day moving average price is $17.38 and its 200-day moving average price is $17.51.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the previous year, the firm earned $0.24 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. On average, equities research analysts forecast that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.